|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Matouk IJ, DeGroot N, Mezan S, Ayesh S,
Abu-lail R, Hochberg A and Galun E: The H19 non-coding RNA is
essential for human tumor growth. PLoS One. 2:e8452007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huarte M, Guttman M, Feldser D, Garber M,
Koziol MJ, Kenzelmann-Broz D, Khalil AM, Zuk O, Amit I, Rabani M,
et al: A large intergenic noncoding RNA induced by p53 mediates
global gene repression in the p53 response. Cell. 142:409–419.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pasmant E, Sabbagh A, Masliah-Planchon J,
Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K,
Valeyrie-Allanore L, et al: Role of noncoding RNA ANRIL in genesis
of plexiform neurofibromas in neurofibromatosis type 1. J Natl
Cancer Inst. 103:1713–1722. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du Y, Kong G, You X, Zhang S, Zhang T, Gao
Y, Ye L and Zhang X: Elevation of highly up-regulated in liver
cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell
proliferation via down-regulating p18. J Biol Chem.
287:26302–26311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ling H, Spizzo R, Atlasi Y, Nicoloso M,
Shimizu M, Redis RS, Nishida N, Gafà R, Song J, Guo Z, et al:
CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic
progression and chromosomal instability in colon cancer. Genome
Res. 23:1446–1461. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li CH and Chen Y: Targeting long
non-coding RNAs in cancers: Progress and prospects. Int J Biochem
Cell Biol. 45:1895–1910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yamada K, Kano J, Tsunoda H, Yoshikawa H,
Okubo C, Ishiyama T and Noguchi M: Phenotypic characterization of
endometrial stromal sarcoma of the uterus. Cancer Sci. 97:106–112.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin R, Maeda S, Liu C, Karin M and
Edgington TS: A large noncoding RNA is a marker for murine
hepatocellular carcinomas and a spectrum of human carcinomas.
Oncogene. 26:851–858. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tseng JJ, Hsieh YT, Hsu SL and Chou MM:
Metastasis associated lung adenocarcinoma transcript 1 is
up-regulated in placenta previa increta/percreta and strongly
associated with trophoblast-like cell invasion in vitro. Mol Hum
Report. 15:725–731. 2009. View Article : Google Scholar
|
|
13
|
Ji Q, Liu X, Fu X, Zhang L, Sui H, Zhou L,
Sun J, Cai J, Qin J, Ren J and Li Q: Resveratrol Inhibits invasion
and metastasis of colorectal cancer cells via MALAT1 mediated
Wnt/β-catenin signal pathway. PLoS One. 8:e787002013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han
Z, Sui H, Tang Y, Wang Y, Liu N, et al: Long non-coding RNA MALAT-1
promotes tumor growth and metastasis in colorectal cancer through
binding to SFPQ and releasing oncogene PTBP-2 from SFPQ/PTBP-2
complex. Br J Cancer. 111:736–748. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Skaftnesmo KO, Prestegarden L, Micklem DR
and Lorens JB: MicroRNAs in tumorigenesis. Curr Pharm Biotechnol.
8:320–325. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hernando E: microRNAs and cancer: Role in
tumorigenesis, patient classification and therapy. Clin Transl
Oncol. 9:155–160. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Faragalla H, Youssef YM, Scorilas A,
Khalil B, White NM, Mejia-Guerrero S, Khella H, Jewett MA, Evans A,
Lichner Z, et al: The clinical utility of miR-21 as a diagnostic
and prognostic marker for renal cell carcinoma. J Mol Diagn.
14:385–392. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koberle V, Kronenberger B, Pleli T, Trojan
J, Imelmann E, Peveling-Oberhag J, Welker MW, Elhendawy M, Zeuzem
S, Piiper A and Waidmann O: Serum microRNA-1 and microRNA-122 are
prognostic markers in patients with hepatocellular carcinoma. Eur J
Cancer. 49:3442–3449. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ivashchenko A, Berillo O, Pyrkova A,
Niyazova R and Atambayeva S: The properties of binding sites of
miR-619-5p, miR-5095, miR-5096 and miR-5585-3p in the mRNAs of
human genes. Biomed Res Int. 2014:7207152014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wapinski O and Chang HY: Long noncoding
RNAs and human disease. Trends Cell Biol. 21:354–361. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Esteller M: Non-coding RNAs in human
disease. Nature Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luo JH, Ren B, Keryanov S, Tseng GC, Rao
UN, Monga SP, Strom S, Demetris AJ, Nalesnik M, Yu YP, et al:
Transcriptomic and genomic analysis of human hepatocellular
carcinomas and hepatoblastomas. Hepatology. 44:1012–1024. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guffanti A, Iacono M, Pelucchi P, Kim N,
Soldà G, Croft LJ, Taft RJ, Rizzi E, Askarian-Amiri M, Bonnal RJ,
et al: A transcriptional sketch of a primary human breast cancer by
454 deep sequencing. BMC Genomics. 10:1632009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Praz V, Jagannathan V and Bucher P:
CleanEx: A database of heterogeneous gene expression data based on
a consistent gene nomenclature. Nucleic Acids Res. 32:(Database
issue). D542–D547. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Davis IJ, Hsi BL, Arroyo JD, Vargas SO,
Yeh YA, Motyckova G, Valencia P, Perez-Atayde AR, Argani P, Ladanyi
M, et al: Cloning of an Alpha-TFEB fusion in renal tumors harboring
the t(6;11) (p21;q13) chromosome translocation. Proc Natl Acad Sci
USA. 100:6051–6056. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lai MC, Yang Z, Zhou L, Zhu QQ, Xie HY,
Zhang F, Wu LM, Chen LM and Zheng SS: Long non-coding RNA MALAT-1
overexpression predicts tumor recurrence of hepatocellular
carcinoma after liver transplantation. Med Oncol. 29:1810–1816.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schmidt LH, Spieker T, Koschmieder S,
Schäffers S, Humberg J, Jungen D, Bulk E, Hascher A, Wittmer D,
Marra A, Hillejan L, et al: The long noncoding MALAT-1 RNA
indicates a poor prognosis in non-small cell lung cancer and
induces migration and tumor growth. J Thorac Oncol. 6:1984–1892.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gutschner T, Hämmerle M and Diederichs S:
MALAT1-a paradigm for long noncoding RNA function in cancer. J Mol
Med (Berl). 91:791–801. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gutschner T, Hämmerle M, Eissmann M, Hsu
J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al:
The noncoding RNA MALAT1 is a critical regulator of the metastasis
phenotype of lung cancer cells. Cancer Res. 73:1180–1189. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng HT, Shi DB, Wang YW, Li XX, Xu Y,
Tripathi P, Gu WL, Cai GX and Cai SJ: High expression of lncRNA
MALAT1 suggests a biomarker of poor prognosis in colorectal cancer.
Int J Clin Exp Pathol. 7:3174–3181. 2014.PubMed/NCBI
|
